# FDA Data Analysis Report
## Medical Imaging & Molecular Diagnostics Signal Intelligence

Generated: 2026-05-29

| Dataset | Count |
|---|---|
| Medical Imaging Events (MRI+CT+Ultrasound+X-ray) | 2322 |
| Molecular Diagnostics Events (Mol Dx+Hematology) | 1383 |
| Total Adverse Events | 3705 |
| Total Recalls | 3300 |

## 1. Data Quality Assessment

### Field Availability (Critical for NLP Pipeline)

| Field | Available | Percentage | Impact on Project |
|-------|-----------|------------|-------------------|
| mdr_text (narratives) | 3618/3705 | **97.7%** | CRITICAL - Input for extraction |
| product_problems | 3644/3705 | 98.4% | HIGH - Ground truth labels |
| patient data | 3704/3705 | 100.0% | MEDIUM - Severity assessment |

### Narrative Statistics

- Total narratives found: 3618
- Average length: 843 chars
- Median length: 569 chars
- Max length: 21510 chars
- Min length: 32 chars
- Events with narrative > 200 chars: 2961 (79.9%)

### Event Type Distribution

| Type | Count | % |
|---|---|---|
| Malfunction | 2740 | 74.0% |
| Injury | 859 | 23.2% |
| No answer provided | 52 | 1.4% |
| Death | 40 | 1.1% |
|  | 8 | 0.2% |
| Other | 6 | 0.2% |

### Product Code Distribution (in sample)

| Code | Count | Domain |
|---|---|---|
| LNH | 507 | MRI |
| LLZ | 503 | Ultrasound |
| QKO | 502 | PCR |
| IYE | 501 | CT X-ray |
| JAK | 500 | CT |
| GKZ | 500 | Hematology |
| MQB | 383 | Molecular Dx |
| IZL | 323 | Digital X-ray |
| JJE | 2 | Other |
| MOS | 1 | Other |
| DRX | 1 | Other |

### Top 20 Manufacturers

| Manufacturer | Count |
|---|---|
| PHILIPS MEDICAL SYSTEMS DMC GMBH | 314 |
|  | 292 |
| PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. | 259 |
| BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES | 216 |
| BECKMAN COULTER | 194 |
| ELEKTA SOLUTIONS AB | 179 |
| SIEMENS HEALTHCARE DIAGNOSTICS, INC. | 177 |
| SIEMENS HEALTHCARE GMBH | 170 |
| GE MEDICAL SYSTEMS, LLC | 137 |
| ABBOTT LABORATORIES | 114 |
| PHILIPS ELECTRONICS NEDERLAND B.V. | 108 |
| COVIDIEN LP - SUPERDIMENSION INC | 99 |
| ELEKTA INC | 93 |
| ORTHO-CLINICAL DIAGNOSTICS | 89 |
| UNK | 64 |
| ROCHE DIAGNOSTICS | 57 |
| VERAN MEDICAL TECHNOLOGIES, INC | 55 |
| FUJIFILM HEALTHCARE CORPORATION | 53 |
| ACCURAY INCORPORATED | 51 |
| MERGE HEALTHCARE | 51 |

### Top 20 Brand Names

| Brand | Count |
|---|---|
| MOSAIQ | 265 |
| INTELLISPACE CARDIOVASCULAR | 209 |
| FC 500 FLOW CYTOMETER | 168 |
| DIGITALDIAGNOST C90 HIGHPERFORMANCE | 100 |
| DIGITALDIAGNOST 4.1 HIGH PERFORMANCE | 78 |
| SARS-COV-2 IGG | 73 |
|  | 65 |
| ILLUMISITE | 59 |
| ELECSYS ANTI-SARS-COV-2 | 57 |
| ADVIA CENTAUR XPT SARS-COV-2 TOTAL (COV2T) | 55 |
| SUPERDIMENSION | 51 |
| MERGE CARDIO | 49 |
| REVOLUTION CT | 46 |
| VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 IGG REAGENT PACK | 39 |
| SYNAPSE PACS | 38 |
| DIGITAL RADIOGRAPHY X-RAY SYSTEM DX-D100 | 38 |
| ATELLICA IM SARS-COV-2 TOTAL (COV2T) | 37 |
| ADVIA CENTAUR SARS-COV-2 TOTAL (COV2T) | 36 |
| BD FACSCANTO II FLOW CYTOMETER | 35 |
| GM85 | 31 |

### Product Problems — Software Relevance Analysis

| Problem | Count | Software-Related? |
|---|---|---|
| Computer Software Problem | 401 | ✅ YES |
| Incorrect, Inadequate or Imprecise Result or Readings | 388 | ✅ YES |
| Adverse Event Without Identified Device or Use Problem | 258 |  |
| Device Handling Problem | 253 |  |
| Device Fell | 234 |  |
| False Positive Result | 215 |  |
| Improper or Incorrect Procedure or Method | 168 | ✅ YES |
| Use of Device Problem | 162 |  |
| Insufficient Device Problem Information | 161 |  |
| False Negative Result | 157 |  |
| Fluid/Blood Leak | 151 |  |
| Application Program Problem | 141 | ✅ YES |
| Detachment of Device or Device Component | 122 |  |
| Unintended System Motion | 72 |  |
| Failure to Transmit Record | 63 | ✅ YES |
| Unintended Movement | 57 |  |
| No Display/Image | 57 | ✅ YES |
| Break | 53 |  |
| Device Operational Issue | 53 |  |
| Sharp Edges | 48 |  |
| Application Program Problem: Parameter Calculation Error | 47 | ✅ YES |
| No Apparent Adverse Event | 46 |  |
| Poor Quality Image | 42 | ✅ YES |
| Patient Data Problem | 40 | ✅ YES |
| Device Displays Incorrect Message | 35 | ✅ YES |
| Loss of Data | 34 | ✅ YES |
| Therapeutic or Diagnostic Output Failure | 31 |  |
| Smoking | 30 |  |
| Output Problem | 28 |  |
| Electrical /Electronic Property Problem | 26 |  |

**Software-related problems: 1660/4610 (36.0%)**

## 2. Recall Data Analysis

### Field Coverage

| Field | Available | % | Project Use |
|---|---|---|---|
| reason_for_recall | 3300/3300 | 100.0% | CAPA ground truth |
| action | 3296/3300 | 99.9% | Corrective action examples |
| root_cause_description | 3300/3300 | 100.0% | Root cause classification |

### Root Cause Distribution

| Root Cause | Count | % |
|---|---|---|
| Software design | 1076 | 32.6% |
| Device Design | 466 | 14.1% |
| Other | 397 | 12.0% |
| Under Investigation by firm | 280 | 8.5% |
| Nonconforming Material/Component | 195 | 5.9% |
| Process control | 126 | 3.8% |
| Radiation Control for Health and Safety Act | 119 | 3.6% |
| Component design/selection | 93 | 2.8% |
| Process design | 82 | 2.5% |
| Unknown/Undetermined by firm | 72 | 2.2% |
| Software change control | 53 | 1.6% |
| Software Design Change | 48 | 1.5% |
| Software design (manufacturing process) | 30 | 0.9% |
| Equipment maintenance | 30 | 0.9% |
| Employee error | 29 | 0.9% |
| Process change control | 22 | 0.7% |
| Component change control | 22 | 0.7% |
| Labeling design | 21 | 0.6% |
| Use error | 18 | 0.5% |
| Pending | 17 | 0.5% |
| Software in the Use Environment | 16 | 0.5% |
| Labeling Change Control | 15 | 0.5% |
| Software Manufacturing/Software Deployment | 12 | 0.4% |
| Mixed-up of materials/components | 12 | 0.4% |
| Error in labeling | 9 | 0.3% |
| Labeling mix-ups | 9 | 0.3% |
| No Marketing Application | 7 | 0.2% |
| Labeling False and Misleading | 6 | 0.2% |
| Vendor change control | 4 | 0.1% |
| PMA | 2 | 0.1% |
| Finished device change control | 2 | 0.1% |
| Packaging process control | 2 | 0.1% |
| Material/Component Contamination | 2 | 0.1% |
| Environmental control | 2 | 0.1% |
| Package design/selection | 1 | 0.0% |
| Storage | 1 | 0.0% |
| Packaging | 1 | 0.0% |
| Incorrect or no expiration date | 1 | 0.0% |

### Recall Reason Text Stats

- Average: 225 chars
- Max: 2031 chars
- Min: 9 chars

## 3. Population-Level Statistics (from API counts)

### Manufacturers Lnh

| Term | Count |
|---|---|
| PHILIPS ELECTRONICS NEDERLAND B.V. | 1,094 |
| PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. | 460 |
| SIEMENS HEALTHINEERS AG | 92 |
| GE MEDICAL SYSTEMS, LLC | 70 |
| FUJIFILM HEALTHCARE CORPORATION | 54 |
| UNK | 40 |
| GE HEALTHCARE (TIANJIN) COMPANY LIMITED | 28 |
| UNKNOWN | 24 |
| SIEMENS HEALTHCARE GMBH - MR | 23 |
| FUJIFILM CORPORATION | 18 |
| SIEMENS HEALTHCARE GMBH | 18 |
| CANON MEDICAL SYSTEMS CORPORATION | 16 |
| GE HEALTHCARE MANUFACTURING LLC | 10 |
| IMRIS - DEERFIELD IMAGING, INC. | 9 |
| SIEMENS SHENZHEN MAGNETIC RESONANCE LTD. | 9 |

### Manufacturers Jak

| Term | Count |
|---|---|
| COVIDIEN LP - SUPERDIMENSION INC | 396 |
| VERAN MEDICAL TECHNOLOGIES, INC. | 71 |
| SIEMENS HEALTHINEERS AG | 59 |
| SIEMENS HEALTHCARE GMBH | 58 |
| VERAN MEDICAL TECHNOLOGIES, INC | 55 |
| NEUROLOGICA CORP | 53 |
| PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. | 44 |
| SIEMENS HEALTHCARE GMBH-CT | 43 |
| PHILIPS HEALTHCARE (SUZHOU) CO., LTD. | 31 |
|  | 27 |
| NEUROLOGICA CORPORATION | 22 |
| GE MEDICAL SYSTEMS, LLC | 17 |
| SAMSUNG HME AMERICA, INC. | 12 |
| SIEMENS MEDICAL SOLUTIONS USA, INC. | 12 |
| GE HANGWEI MEDICAL SYSTEMS CO., LTD. | 11 |

### Recall Roots Imaging

| Term | Count |
|---|---|
| Software design | 750 |
| Other | 239 |
| Device Design | 215 |
| Under Investigation by firm | 181 |
| Nonconforming Material/Component | 114 |
| Process control | 85 |
| Radiation Control for Health and Safety Act | 82 |
| Process design | 75 |
| Unknown/Undetermined by firm | 69 |
| Component design/selection | 53 |
| Software change control | 37 |
| Software Design Change | 29 |
| Equipment maintenance | 26 |
| Process change control | 21 |
| Employee error | 18 |

### Recall Roots Moldx

| Term | Count |
|---|---|
| Other | 88 |
| Software design | 82 |
| Device Design | 76 |
| Under Investigation by firm | 36 |
| Nonconforming Material/Component | 35 |
| Process control | 22 |
| Radiation Control for Health and Safety Act | 20 |
| Component design/selection | 16 |
| Pending | 13 |
| Employee error | 9 |
| Software change control | 9 |
| Component change control | 6 |
| Labeling Change Control | 5 |
| Software Design Change | 4 |
| Labeling design | 3 |

### Brand Names Lnh

| Term | Count |
|---|---|
| ACHIEVA 1.5T DSTREAM | 348 |
| ACHIEVA 1.5T NEW | 228 |
| INGENIA | 184 |
| ACHIEVA 3.0T DSTREAM | 105 |
| INGENIA 3.0T | 84 |
| ACHIEVA 1.5T NOVA | 83 |
| ACHIEVA 3.0T TX | 70 |
| ACHIEVA 3.0 T | 57 |
| INGENIA 1.5T | 56 |
| ACHIEVA 3.0T NEW | 38 |
| INTERA 1.5T PULSAR NEW | 34 |
| ACHIEVA 1.5T | 31 |
| ACHIEVA 1.5T CONVERSION | 29 |
| SMARTPATH TO DSTREAM FOR XR AND 3.0T | 29 |
| MRI | 27 |

### Brand Names Jak

| Term | Count |
|---|---|
| ILLUMISITE | 316 |
| SUPERDIMENSION | 48 |
| SOMATOM DEFINITION AS | 33 |
|  | 31 |
| EDGE | 27 |
| NL5000 | 27 |
| INCISIVE CT | 26 |
| SOMATOM FORCE | 24 |
| SOMATOM DEFINITION FLASH | 18 |
| BRILLIANCE | 14 |
| NL3000 | 14 |
| NL4000 | 13 |
| SOMATOM DRIVE | 13 |
| ALWAYS-ON TIP TRACKED 22GA ANSO FLEXIBLE NEEDLE | 12 |
| SOMATOM X.CITE | 12 |

## 4. BLOCKERS & RISKS

### 🔴 Critical

1. ✅ Good narrative coverage (98%). NLP pipeline has sufficient input.

2. **COMBINED DATA SIZE**: Medical imaging events (~33K) are more manageable than infusion pumps (1.94M), but API pagination limits to 26K results per query.
   - MITIGATION: For MRI+CT+IYE (combined ~13K), API pagination is sufficient!
   - For ultrasound (19K), need multiple date-ranged queries or bulk download.

3. **PRODUCT_PROBLEMS FIELD SPARSE**: Only structured problem codes are available for 98% of events.
   - MITIGATION: Use narratives as primary input. Product_problems is bonus ground truth.

### 🟡 Medium Risks

4. **IMAGING EVENTS ARE HARDWARE-HEAVY**: Many events are mechanical/electrical (coil heating, table movement, physical burns), not software.
   - MITIGATION: Pre-filter using keywords: 'software', 'image', 'display', 'artifact', 'algorithm', 'reconstruction', 'processing', 'data loss', 'DICOM'.
   - The CT recalls explicitly mention 'Software Design' as root cause — good signal.

5. **MOLECULAR DX EVENTS MAY BE COVID-DOMINATED**: QJR (20K events) is mostly COVID rapid tests which may skew the dataset.
   - MITIGATION: Focus on MQB (instrument-level) and GKZ (hematology analyzers) which are platform/software issues, not test strip failures.

6. **RECALL DATA IS BETTER THAN EVENTS FOR SOFTWARE FAILURES**: Recalls explicitly cite 'Software Design' as root cause and describe the fix.
   - OPPORTUNITY: 2,830 imaging recalls + 589 mol dx recalls = 3,419 total. This is a RICH dataset for CAPA training and Graph RAG.

7. **MULTIPLE MANUFACTURERS ADD COMPLEXITY**: Philips, Siemens, GE Healthcare all report differently. Entity resolution needed.
   - MITIGATION: Normalize manufacturer names in preprocessing. Use knowledge graph.

### 🟢 Advantages Over Infusion Pumps

8. ✅ **More manageable volume**: 33K imaging events vs 1.94M infusion pump events
9. ✅ **Richer recall data**: 2,830 imaging recalls with detailed root causes and actions
10. ✅ **Clear software failures**: CT/MRI recalls explicitly cite 'Software Design' root cause
11. ✅ **Multi-domain**: MRI + CT + Ultrasound + Molecular Dx shows system generalization
12. ✅ **AI/ML relevance**: Image reconstruction, CAD algorithms, DICOM processing — all software
13. ✅ **Major manufacturers**: Philips, Siemens, GE — well-documented device families
14. ✅ **API pagination feasible**: Most product codes have <26K events — no bulk download needed

## 5. OVERSTATEMENTS AUDIT (System_Design.md)

| Claim | Reality | Fix |
|---|---|---|
| 'In 2 minutes' | LLM API latency + 6 agents + retrieval = 3-8 min realistic | Change to '< 10 minutes' |
| '5x faster' | No baseline measured. Industry avg unknown | Remove or say 'significantly faster' |
| '87% confidence' | Fabricated for demo illustration | Label as 'illustrative' or remove |
| 'First application of DPO/RLHF' | Can't verify without lit review | Say 'novel in this domain' |
| '1.94M events implies using all' | We'll use ~5-15K subset | Clarify actual working set |
| '18 techniques deeply' | Can't deeply implement 18 in 4 weeks | Tier: 6 core, 6 extended, 6 stretch |
| 'PPO training' | PPO is unstable, needs 100+ GPU-hrs | Lead with DPO, PPO as comparison |
| 'Contrastive embeddings' | Needs 500+ pairs minimum to converge | Mark as Week 3 stretch goal |
| 'Knowledge distillation' | Needs eval infrastructure first | Mark as ablation experiment |
| 'Production pathway' | Academic project, not production-ready | Frame as 'proof of concept' |

## 6. COLLABORATION STRATEGY (6 Members, 4 Weeks)

### Member Assignments (Revised for Imaging/MolDx)

| Member | Primary Responsibility | Secondary |
|---|---|---|
| M1 | Data pipeline + Embeddings | Entity resolution for manufacturers |
| M2 | Agent 3 (FDA Retrieval) + Knowledge Graph | Pipeline integration |
| M3 | Agent 1 (Extraction) + DSPy optimization | Agent 6 (Report) |
| M4 | Agent 2 (Similarity/Clustering) + Dashboard | UMAP visualizations |
| M5 | Agent 4 (Risk) + Agent 5 (CAPA) + DPO | Alignment experiments |
| M6 | Evaluation framework + LLM-as-Judge | Gold standard labeling |

### JSON Schema Contracts (Define in Week 1)

```json
// Agent 1 Output → Agents 2,3,4 Input
{
  "report_id": "string",
  "modality": "MRI|CT|Ultrasound|MolDx",
  "component": "string (e.g., image reconstruction, DICOM gateway)",
  "failure_mode": "string (e.g., image artifact, data loss, incorrect result)",
  "symptom": "string",
  "severity_indicator": "string",
  "manufacturer": "string (normalized)",
  "device_model": "string",
  "patient_impact": "string|null",
  "discovery_phase": "in-use|maintenance|calibration|qa-check",
  "software_related": true,
  "confidence": 0.0
}
```

### Collaboration Risks

| Risk | Impact | Mitigation |
|---|---|---|
| Integration breaks at agent boundaries | HIGH | JSON schema contracts frozen end of Week 1 |
| One member's agent blocks downstream | HIGH | Mock inputs for each agent; standalone testing |
| Data too large for Git | MEDIUM | .gitignore data/. Script re-downloads. Share embeddings via cloud |
| API key sharing | MEDIUM | .env files. Single shared key with rate awareness |
| GPU contention for DPO/fine-tuning | MEDIUM | Schedule: M5 Mon-Wed, M6 Thu-Fri, M1 weekends |
| Evaluation needs all agents running | HIGH | LLM-as-Judge evaluates each agent independently |
| Merge conflicts | LOW | Each member owns their agent .py file |

### Repository Structure

```
imaging-signal-intelligence/
├── data/                       # .gitignored
│   ├── imaging_events/         # MRI+CT+Ultrasound+X-ray
│   ├── molecular_dx_events/    # Mol Dx + Hematology
│   ├── recalls/                # All recalls
│   ├── embeddings/             # Shared via cloud storage
│   └── analysis/               # Reports and stats
├── src/
│   ├── agents/                 # One file per agent (clear ownership)
│   │   ├── extraction.py       # M3
│   │   ├── similarity.py       # M4
│   │   ├── retrieval.py        # M2
│   │   ├── risk.py             # M5
│   │   ├── capa.py             # M5
│   │   └── report.py           # M3
│   ├── pipeline/
│   │   ├── orchestrator.py     # M2 (integration)
│   │   └── schemas.py          # SHARED - frozen Week 1
│   ├── data_processing/        # M1
│   ├── embeddings/             # M1 + M4
│   ├── evaluation/             # M6
│   ├── alignment/              # M5
│   └── dashboard/              # M4
├── notebooks/                  # Each member owns theirs
├── configs/                    # Prompts, model configs
├── tests/                      # Unit tests per agent
└── docs/                       # Final report, poster
```

### Communication Protocol

1. **Daily async standup** (Slack/Teams): What done, what next, what blocks
2. **Schema freeze**: End of Week 1 — JSON contracts locked
3. **Integration checkpoint**: End of each week — run `pytest tests/`
4. **Code reviews**: Before merging to main, at least 1 peer review
5. **Shared artifacts**: Embeddings generated Week 1 by M1, shared via Google Drive
6. **Demo rehearsal**: Week 4 Day 3 — full end-to-end run with 5 examples

## 7. RECOMMENDED WORKING DATASET

| Dataset | Size | Source | When |
|---|---|---|---|
| MRI events (LNH, 2019-2026, with narratives) | ~3,000 | API pagination | Week 1 Day 1 |
| CT events (JAK+IYE, 2019-2026, with narratives) | ~5,000 | API pagination | Week 1 Day 1 |
| Ultrasound events (LLZ, 2019-2026, with narratives) | ~8,000 | API (multiple queries) | Week 1 Day 1-2 |
| Molecular Dx events (MQB+GKZ, with narratives) | ~3,000 | API pagination | Week 1 Day 2 |
| All imaging recalls | ~2,830 | API (done ✅) | Done |
| All mol dx recalls | ~589 | API (done ✅) | Done |
| Synthetic internal defect reports | 200 | GPT-4 generation | Week 1 Day 3-4 |
| Gold-standard labeled set | 50 | Manual team labeling | Week 1 Day 4-5 |
| **Total working set** | **~20,000 events + 3,419 recalls** | | |

### Why This Is Better Than 1.94M Infusion Pump Events

- **Manageable**: 20K events can be fully embedded in hours, not days
- **Multi-domain**: Shows system works across MRI, CT, Ultrasound, Mol Dx
- **Software-rich recalls**: Imaging recalls explicitly cite software design failures
- **API-feasible**: No bulk download needed — all fits within API pagination limits
- **Diverse manufacturers**: Philips, Siemens, GE — entity resolution challenge
- **Realistic**: A QM would actually assess across their imaging fleet, not one product

## 8. SAMPLE NARRATIVES (Team Review)

**Sample 1** — LNH | SIGNA ARCHITECT
- Event type: Injury
- Problems: ['Use of Device Problem', 'Adverse Event Without Identified Device or Use Problem']
- Narrative: "THE INVESTIGATION BY GE HEALTHCARE (GEHC) HAS BEEN COMPLETED. THE MR SYSTEM WAS OPERATING WITHIN SPECIFICATIONS AND ALL SAFETY MITIGATING DEVICES WERE FUNCTIONAL WHEN CHECKED BY THE GEHC FIELD ENGINEER. THE ROOT CAUSE OF THE INJURY WAS DETERMINED TO BE INADEQUATE PATIENT PADDING FOR THE MRI PROCEDURE. THE OPERATOR DOCUMENTATION DESCRIBES THE APPROPRIATE SAFETY MEASURES FOR PADDING PATIENTS FOR MR "

**Sample 2** — LNH | POLESTAR N30 SURGICAL MRI SYSTEM
- Event type: Malfunction
- Problems: ['Computer Software Problem']
- Narrative: "MEDTRONIC RECEIVED INFORMATION REGARDING AN IMAGING SYSTEM BEING USED FOR A CRANIAL RESECTION PROCEDURE. DURING IMAGE ACQUISITION, AN ERROR WAS RECEIVED ("EREPORT: ACQUISITION ERROR: SELECT ANOTHER PROTOCOL"). THE ISSUE RESULTED IN LESS THAN ONE HOUR PROCEDURE DELAY. THE PROCEDURE WAS COMPLETED WITHOUT THE USE OF IMAGING. THERE WAS NO IMPACT ON PATIENT OUTCOME. THE IMAGING SYSTEM WAS REPORTED AS D"

**Sample 3** — LNH | MAGNETOM SKYRA
- Event type: Injury
- Problems: ['Use of Device Problem']
- Narrative: "SIEMENS COMPLETED AN INVESTIGATION OF THE REPORTED INCIDENT. OUR EXPERTS ANALYZED THE IMAGES GENERATED DURING THE PATIENT EXAMINATION. THE COMPLETE EXAMINATION OF THE PATIENT'S RIGHT SHOULDER CONTINUED FOR 82.2 MIN WITH AN ACTIVE SCANNING TIME OF 58.2 MIN (NOTE: THESE ARE LONG DURATIONS). NO ABNORMALITY WAS FOUND WHICH WOULD INDICATE A SYSTEM MALFUNCTION. THE COMPLETE MEASUREMENT WAS PERFORMED IN "

**Sample 4** — LNH | MAGNETOM TERRE 7T MRI
- Event type: Injury
- Problems: ['Adverse Event Without Identified Device or Use Problem']
- Narrative: "SCHEDULED FOR 3 MRI SAME AFTERNOON AT (B)(6) HOSPITAL (B)(6): CERVICAL, THORACIC AND LUMBAR TO DETERMINE STATUS OF LOW BACK AS CONSIDERATION BEING MADE TO SURGICALLY PROCEED WITH HIGH CERVICAL TO MID THORACIC FUSION W/ INSTRUMENTATION DUE TO MASS EFFECT ON SPINAL CORD AT T2. DURING CERVICAL PORTION OF MRI (MACHINE: 7T MAGNETOM TERRE BY SIEMENS MEDICAL SOLUTIONS) BURNING OCCURRED IN CHEST, ADVISED "

**Sample 5** — LNH | DISCOVERY MR750W GEM - 70CM
- Event type: Injury
- Problems: ['Adverse Event Without Identified Device or Use Problem']
- Narrative: "PATIENT RECEIVED A MINOR THERMAL BURN IN THE SACRAL AREA DURING MRI OF PROSTATE EXAM. FDA SAFETY REPORT ID# (B)(4)."

**Sample 6** — LNH | GE TWINSPEED 1.5 TESLA MRI
- Event type: Injury
- Problems: ['Adverse Event Without Identified Device or Use Problem']
- Narrative: "AN MRI OF THE LUMBAR SPINE WITH AND WITHOUT CONTRAST WAS PERFORMED ON THE PATIENT AT APPROXIMATELY 8:00 AM. THE PATIENT DID NOT COMPLAIN OF ANY ADVERSE SIGNS OR SYMPTOMS THROUGHOUT THE PERFORMANCE OF THE EXAMINATION. THE PATIENT CALLED BACK TO THE FACILITY APPROXIMATELY 6 HOURS LATER, COMPLAINING OF A BLISTER ON HER LEG. THE PATIENT STATED THAT SHE FELT A BURNING IN HER LEG DURING THE MRI BUT THOU"

**Sample 7** — LNH | MRI MACHINE
- Event type: Injury
- Problems: ['Adverse Event Without Identified Device or Use Problem']
- Narrative: "HEARING PROBLEMS DUE TO EXCRUCIATING NOISE. HORRIBLE EARACHES AND RINGING IN EARS. APPT AT 6 PM FOR MRI AT ENVISION IMAGING - (B)(6). FILLED OUT PAPERWORK AND TAKEN TO DRESSING ROOM AND REMOVED ITEMS. TAKEN TO MRI MACHINE, GIVEN CHEAP EAR PLUGS? LAID ON BOARD AND ENTERED MACHINE, ONLY TO BE TORTURED BY THE EXTREMELY LOUD NOISES FROM MACHINE. IT KILLED MY HEARING AND RINGING IN MY EAR STILL THERE A"

**Sample 8** — LNH | MRI
- Event type: Injury
- Problems: ['Adverse Event Without Identified Device or Use Problem']
- Narrative: "I AM DIABETIC AND HAVE MS. WENT TO (B)(6) FOR A DOCTOR VISIT AND BRAIN MRI. FOR THE MRI, I WAS TOLD I COULD LEAVE STREET CLOTHES ON EXCEPT REMOVE MY BELT, WHICH I DID. THE SHORTS I WAS WEARING HAD A METAL ZIPPER AND HAD A METAL BUTTON. THERE WERE BUTTONS ON THE SHIRT OF UNKNOWN CONTENT. I WAS NOT PADDED IN ANY WAY. JUST A SHEET OVER ME. I QUESTIONED THE TECHNICIAN ABOUT WEARING THE SHORTS AND WAS "

**Sample 9** — LNH | MAGNETOM SOLA
- Event type: Malfunction
- Problems: ['Use of Device Problem']
- Narrative: "SIEMENS IS CONDUCTING A THOROUGH INVESTIGATION OF THE REPORTED EVENTS. AS THIS EVENT IS UNDER INVESTIGATION, A FINAL ROOT CAUSE HAS NOT YET BEEN DETERMINED. A SUPPLEMENT REPORT WILL BE FILED UPON COMPLETION OF THE INVESTIGATION. INTERNAL ID # (B)(4)."

**Sample 10** — LNH | MAGNETOM AVANTO DOT
- Event type: Injury
- Problems: ['Use of Device Problem']
- Narrative: "SIEMENS IS CONDUCTING A THOROUGH INVESTIGATION OF THE REPORTED EVENTS. AS THIS EVENT IS UNDER INVESTIGATION, A FINAL ROOT CAUSE HAS NOT YET BEEN DETERMINED. A SUPPLEMENT REPORT WILL BE FILED UPON COMPLETION OF THE INVESTIGATION. INTERNAL ID # (B)(4)."

**Sample 11** — LNH | GE 3.0T HDXT 23.0 MRI
- Event type: Injury
- Problems: ['Improper or Incorrect Procedure or Method', 'Device Damaged by Another Device', 'Electromagnetic Compatibility Problem']
- Narrative: "MRI TECHNOLOGIST ALLOWED A PATIENT TO ENTER INTO A 3T MRI IMAGING SUITE WITH A FERROMAGNETIC KNEE SCOOTER. THE SCOOTER WAS PULLED TO THE MAGNET ALONG WITH THE PATIENT. THE PATIENT'S THUMB WAS PINCHED BETWEEN THE HANDLE BARS AND THE MAGNET FACE. THE PATIENT WAS ABLE TO PULL HER THUMB FREE AND ESCAPED WITH ONLY A GASH IN HER THUMB. THE PATIENT REFUSED TO BE SEEN BY THE EMERGENCY DEPARTMENT PHYSICIAN"

**Sample 12** — LNH | VANTAGE TITAN 3T
- Event type: Malfunction
- Problems: ['Device Emits Odor', 'Loss of Power']
- Narrative: "PATIENT WAS BROUGHT TO MRI FOR A SCAN OF BRAIN, CERVICAL AND THORACIC SPINE. SCAN WAS STARTED AT 0645. BRAIN AND CERVICAL SPINE WERE DONE, AND THORACIC EXAM WAS 50% COMPLETE WHEN THE SCANNER ABORTED DURING A SEQUENCE. THE SCANNER WAS REBOOTED TWICE BUT WOULD NOT SCAN. A STRONG ELECTRICAL ODOR WAS NOTICED COMING FROM THE SCANNER BORE AREA. THE PATIENT WAS REMOVED FROM THE SCAN ROOM IMMEDIATELY AND "

## 9. TECHNIQUE PRIORITIZATION (Realistic for 4 Weeks)

### Core (MUST implement — these define the project)

| # | Technique | Agent | Why Core |
|---|---|---|---|
| 1 | RAG (Vector + Semantic) | Agent 3 | Foundation of evidence retrieval |
| 2 | Chain-of-Thought Extraction | Agent 1 | Structured output from narratives |
| 3 | Sentence-Transformer Embeddings | Agent 2 | Clustering and similarity |
| 4 | HDBSCAN + UMAP | Agent 2 | Pattern detection and visualization |
| 5 | ReAct Pattern | Agent 3 | Tool-augmented retrieval |
| 6 | Self-Reflection / Critique-Revise | Agent 4, 6 | Hallucination reduction |

### Extended (SHOULD implement — demonstrates depth)

| # | Technique | Agent | Effort |
|---|---|---|---|
| 7 | DSPy Prompt Optimization | Agent 1 | Medium (2-3 days) |
| 8 | DPO Alignment | Agent 5, 6 | Medium (needs 50+ preference pairs) |
| 9 | Graph RAG | Agent 3 | Medium (knowledge graph build) |
| 10 | LLM-as-Judge | Eval | Medium (prompt design + calibration) |
| 11 | Temporal Anomaly Detection | Agent 2 | Low-Medium (stats on clusters) |
| 12 | Constrained Decoding / JSON Schema | Agent 1, 4 | Low (use tool calling) |

### Stretch (NICE TO HAVE — if time permits)

| # | Technique | Effort | Risk |
|---|---|---|---|
| 13 | Contrastive Fine-tuning | High | Needs 500+ pairs, may not converge |
| 14 | PPO (compare with DPO) | High | Unstable training, needs GPU time |
| 15 | Knowledge Distillation | High | Needs working system first |
| 16 | Active Learning | Medium | Needs iteration loop infrastructure |
| 17 | LoRA Fine-tuning | High | Needs GPU + training data |
| 18 | MCP Tool Integration | Medium | Nice demo, not research contribution |

